Internal Medicine, Hematology & Oncology · Torrance, CA
NPI
1972786895
Since 2007
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
5215 Torrance Blvd
Torrance, CA, 90503
Phone (310) 750-1715
Groups this clinician bills Medicare through
Medicare paid, 2024
$1.8M
96,504 services
Medicare patients, 2024
304
Average age 75
Drug cost, 2024
$5.8M
1,176 prescriptions
Company payments, 2025
$316
From 3 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Reza Mostofi was code J0185 (injection, aprepitant, 1 mg), 9,880 times for 18 patients. In total Reza Mostofi billed 96,504 services in 105 codes, and Medicare paid $1.8M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-11-18.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0185 Injection, aprepitant, 1 mg | Office | 9,880 | 18 | $1.30 | $13K |
| J0897 Injection, denosumab, 1 mg | Office | 6,180 | 30 | $20.14 | $124K |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 1,884 | 32 | $0.09 | $171 |
| J2405 Injection, ondansetron hydrochloride, per 1 mg | Office | 1,840 | 30 | $0.08 | $139 |
| 99214 Office E&M - Established | Office | 600 | 202 | $100.59 | $60K |
| 96375 Injection Administration | Office | 468 | 44 | $14.19 | $6,640 |
| J2506 Injection, pegfilgrastim, excludes biosimilar, 0.5 mg | Office | 408 | 12 | $47.65 | $19K |
| 96413 Chemotherapy Administration | Office | 285 | 52 | $121.79 | $35K |
| 96372 Injection Administration | Office | 196 | 46 | $12.82 | $2,513 |
| 99215 Office E&M - Established | Office | 103 | 70 | $144.44 | $15K |
| J1200 Injection, diphenhydramine hcl, up to 50 mg | Office | 87 | 15 | $0.65 | $56.59 |
| J3490 Unclassified drugs | Office | 74 | 12 | $0.61 | $44.92 |
| 96417 Chemotherapy Administration | Office | 65 | 15 | $60.16 | $3,910 |
| 99205 Office E&M - New | Office | 64 | 64 | $168.42 | $11K |
| 96367 Intravenous Infusion, Hydration | Office | 60 | 17 | $26.46 | $1,587 |
By year: 2022 $1.8M for 102,745 services; 2023 $3.0M for 160,517 services; 2024 $1.8M for 96,504 services.
Medicare prescription drug claims, 2024
In 2024, the drug Reza Mostofi prescribed most often to Medicare patients was Anastrozole, with 162 prescriptions and refills. In total Reza Mostofi wrote 1,176 Medicare prescriptions that cost $5.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Anastrozole Generic | 162 | 368 | 44 | $2,912 |
| Revlimid Lenalidomide | 85 | 85 | 13 | $1.4M |
| Ondansetron Odt Ondansetron | 65 | 65 | 39 | $551 |
| Tagrisso Osimertinib Mesylate | 65 | 65 | Under 11 | $1.0M |
| Dexamethasone Generic | 45 | 48 | 24 | $1,008 |
| Prochlorperazine Maleate Generic | 44 | 44 | 29 | $747 |
| Prednisone Generic | 43 | 43 | 13 | $361 |
| Abiraterone Acetate Generic | 41 | 41 | Under 11 | $117K |
| Acyclovir Generic | 40 | 60 | Under 11 | $374 |
| Darzalex Faspro Daratumumab-Hyaluronidase-Fihj | 32 | 32 | Under 11 | $562K |
| Eliquis Apixaban | 25 | 50 | Under 11 | $28K |
| Olanzapine Generic | 23 | 33 | 12 | $392 |
| Pantoprazole Sodium Generic | 23 | 39 | Under 11 | $327 |
| Zejula Niraparib Tosylate | 22 | 22 | Under 11 | $410K |
| Furosemide Generic | 20 | 42 | Under 11 | $38.37 |
Brand drugs: 427 claims; generic drugs: 749 claims; opioid claims: 20.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Reza Mostofi $316 ($316 in general payments such as food, travel and fees) from 3 companies. The largest payer was Sirtex Medical Inc with $143.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.